Document is current
Any future updates will be listed below
-
Authors
Venkatachalam, Nachiyappan
Wang, Li
Muthukumarana, Niyumi
Ihnatko, Robert
Krijgsveld, Jeroen
Skabkina, Olga
Leipertz, Antonia
Chen, Yubin
Sui, Ping
Zheng, Qing
Tong, Panpan
Liu, Xi
Descot, Arnaud
Schewe, Matthias
Diamante, Gabriele
Jackstadt, Rene
Brochhausen, Christoph
Betge, Johannes
Boonekamp, Kim
Boutros, Michael
Stoecklin, Georg
Ebert, Matthias
Schott, Johanna
Zhan, Tianzuo
-
Funding
Funding for this research was provided by:
Ruprecht-Karls-Universität Heidelberg
- License Information
-
More Information
Article History
Received: 16 January 2026
Accepted: 15 May 2026
First Online: 27 May 2026
Declarations
:
: Experiments with patient-derived cancer organoids were approved by the Medical Ethics Committee II of the Medical Faculty Mannheim, Heidelberg University (Reference no. 2014–633 N-MA and 2016–607 N-MA). Written informed consent was obtained from patients before performing any experimental procedures.
: Not applicable.
: The authors declare no competing interests.
